You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with mild cognitive impairment or mild Alzheimer’s disease dementia (ROMEMA): study protocol of a double-blind, randomized, placebo-controlled, between-subjects trial
|
|---|---|
| Published in |
Trials, March 2024
|
| DOI | 10.1186/s13063-024-08001-3 |
| Pubmed ID | |
| Authors |
Nina Possemis, Frans Verhey, Jos Prickaerts, Arjan Blokland, Inez Ramakers |
Mendeley readers
The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 6 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 2 | 33% |
| Unspecified | 2 | 33% |
| Lecturer | 1 | 17% |
| Unknown | 1 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Unspecified | 3 | 50% |
| Linguistics | 2 | 33% |
| Unknown | 1 | 17% |